Fertility and Sterility
Volume 93, Issue 4 , Pages 1299-1307, 1 March 2010

Protective effects of telmisartan on ischemia/reperfusion injury of rat ovary: biochemical and histopathologic evaluation

  • Yakup Kumtepe, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Ataturk University School of Medicine, Erzurum, Turkey
    • Corresponding Author InformationReprint requests: Dr. Yakup Kumtepe, Obstetrics and Gynecology, Faculty of Medicine, Ataturk University, Terminal cad no. 14/2, 25200 Erzurum, Turkey (FAX: +90 442 236 0968).
  • ,
  • Fehmi Odabasoglu, Ph.D.

      Affiliations

    • Department of Biochemistry, Ataturk University School of Pharmacy, Erzurum, Turkey
  • ,
  • Mehmet Karaca, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Kafkas University School of Medicine, Kars, Turkey
  • ,
  • Beyzagul Polat, M.Sc.

      Affiliations

    • Department of Pharmacology, Ataturk University School of Medicine, Erzurum, Turkey
  • ,
  • Mesut Bünyamin Halici, Ph.D.

      Affiliations

    • Department of Biochemistry, Ataturk University School of Pharmacy, Erzurum, Turkey
  • ,
  • Osman Nuri Keles, M.Sc.

      Affiliations

    • Department of Histology and Embryology, Ataturk University School of Medicine, Erzurum, Turkey
  • ,
  • Zuhal Altunkaynak, Ph.D.

      Affiliations

    • Department of Histology and Embryology, Ataturk University School of Medicine, Erzurum, Turkey
  • ,
  • Fatma Gocer, M.D.

      Affiliations

    • Department of Pharmacology, Ataturk University School of Medicine, Erzurum, Turkey

Received 1 August 2008; received in revised form 28 November 2008; accepted 8 December 2008. published online 06 February 2009.

Objective

To evaluate the effects of telmisartan as an antioxidant and for its tissue protective properties and to study the biochemical and histopathologic changes in experimental ischemia and ischemia/reperfusion injuries in rat ovaries.

Design

Experimental study.

Setting

Experimental surgery laboratory in a university department.

Animal(s)

Forty-eight female adult rats.

Intervention(s)

I: sham operation; II: bilateral ovarian ischemia; III: 3 h ischemia + 3 h reperfusion. IV and V: Rats were administered 10 and 20 mg/kg doses of telmisartan, respectively, before 0.5 h of ischemia, and then ovarian ischemia was applied; after 3 h of ischemia, the ovaries were removed. VI and VII: 3 h ovarian ischemia was applied; 2.5 h after the induction of ischemia, rats were administered the same doses of telmisartan; at the end of 3 h of ischemia, the ovaries were removed and a 3 h reperfusion followed.

Main Outcome Measure(s)

Superoxide dismutase, inducible nitric oxide synthase, and myeloperoxidase activity in rat ovarian tissue; and histopathologic changes in the ovarian tissue of the rats.

Result(s)

Ischemia and ischemia-reperfusion increased the inducible nitric oxide synthase and myeloperoxidase activity while decreasing the super oxide dismutase activity significantly in comparison with the sham group. Before ischemia and ischemia/reperfusion, telmisartan reversed the trend in inducible nitric oxide synthase activities and the level of myeloperoxidase.

Conclusion(s)

telmisartan is effective in reversing tissue damage induced by ischemia/reperfusion in ovaries.

Key Words: telmisartan, iNOS, ovarian, rat, torsion, ischemia, reperfusion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Y.K. has nothing to disclose. F.O. has nothing to disclose. M.K. has nothing to disclose. B.P. has nothing to disclose. M.B.H. has nothing to disclose. O.N.K. has nothing to disclose. Z.A. has nothing to disclose. F.G. has nothing to disclose.

PII: S0015-0282(08)04662-1

doi:10.1016/j.fertnstert.2008.12.016

Fertility and Sterility
Volume 93, Issue 4 , Pages 1299-1307, 1 March 2010